US Stock MarketDetailed Quotes

CMRX Chimerix

Watchlist
  • 2.990
  • +0.140+4.91%
Close Dec 20 16:00 ET
  • 3.039
  • +0.049+1.62%
Post 20:01 ET
268.91MMarket Cap-3.18P/E (TTM)

About Chimerix Company

Chimerix, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes Brincidofovir for the treatment of adenovirus, cytomegalovirus, and smallpox. The company was founded in April 2000 and is headquartered in Durham, NC.

Company Profile

SymbolCMRX
Company NameChimerix
Listing DateApr 11, 2013
Issue Price14.00
Founded2000
CEOMr. Michael T. Andriole
MarketNASDAQ
Employees72
Fiscal Year Ends12-31
Address2505 Meridian Parkway,Suite 100
CityDurham
ProvinceNorth Carolina
CountryUnited States of America
Zip Code27713
Phone1-919-806-1074

Company Executives

  • Name
  • Position
  • Salary
  • Michael T. Andriole
  • Director, Chief Executive Officer and President
  • 1.31M
  • Michelle LaSpaluto
  • Chief Financial Officer
  • --
  • Thomas J. Riga
  • Chief Operating Officer and Chief Commercial Officer
  • --
  • Dr. Allen S. Melemed
  • Chief Medical Officer
  • 931.79K
  • David Jakeman
  • Vice President, Finance and Accounting and Principal Accounting Officer
  • --
  • Dr. Michael A. Alrutz,PhD
  • Senior Vice President, General Counsel and Corporate Secretary
  • 793.85K
  • Michael Sherman
  • Chairman of the Board
  • 1.52M
  • Marc D. Kozin
  • Director
  • --
  • Victoria Vakiener
  • Independent Director
  • 107.02K
  • Martha J. Dei
  • Lead Independent Director
  • 144.52K
  • Dr. Robert J. Meyer, M.D.
  • Independent Director
  • 117.02K
  • Fred A. Middleton
  • Independent Director
  • 119.52K
  • Patrick C. Machado, J.D.
  • Independent Director
  • 124.52K
  • Lisa Lynn Decker, PhD
  • Independent Director
  • 67.78K
  • Dr. Pratik S. Multani, M.D.
  • Independent Director
  • 104.52K
Heat List
US
Overall
Symbol
Price
% Chg

No Data